Cargando…

Neurodegenerative disorders: the Glia way forward

Detalles Bibliográficos
Autores principales:	Barker, Roger A., Cicchetti, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097031/ https://www.ncbi.nlm.nih.gov/pubmed/25076908 http://dx.doi.org/10.3389/fphar.2014.00157

Ejemplares similares

The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
por: Cicchetti, Francesca, et al.
Publicado: (2014)

Current Understanding of the Glial Response to Disorders of the Aging CNS
por: Barker, Roger A, et al.
Publicado: (2012)

Dysfunctional glia: contributors to neurodegenerative disorders
por: Sidoryk-Węgrzynowicz, Marta, et al.
Publicado: (2020)

The Life Cycle of Health Technologies. Challenges and Ways Forward
por: Gutiérrez-Ibarluzea, Iñaki, et al.
Publicado: (2017)

Drosophila Glia: Models for Human Neurodevelopmental and Neurodegenerative Disorders
por: Kim, Taejoon, et al.
Publicado: (2020)

Advances in computational frameworks in the fight against TB: The way forward
por: Naidu, Akshayata, et al.
Publicado: (2023)

Tau: A Common Denominator and Therapeutic Target for Neurodegenerative Disorders
por: Maxan, Alexander, et al.
Publicado: (2018)

Imaging of Microglia in Patients with Neurodegenerative Disorders
por: Politis, Marios, et al.
Publicado: (2012)

History of Innate Immunity in Neurodegenerative Disorders
por: McGeer, Patrick L., et al.
Publicado: (2011)

Amylin at the interface between metabolic and neurodegenerative disorders
por: Lutz, Thomas A., et al.
Publicado: (2015)

Neuroinflammation as a Common Feature of Neurodegenerative Disorders
por: Guzman-Martinez, Leonardo, et al.
Publicado: (2019)

Pharmacologic Approaches for the Management of Apathy in Neurodegenerative Disorders
por: Bogdan, Anamaria, et al.
Publicado: (2020)

Cannabidiol for neurodegenerative disorders: A comprehensive review
por: Bhunia, Sukanya, et al.
Publicado: (2022)

Rev-erbs and Glia—Implications for Neurodegenerative Diseases
por: Griffin, Percy, et al.
Publicado: (2019)

Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
por: Shah, Sweta, et al.
Publicado: (2021)

Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward
por: Ngum, Nancy, et al.
Publicado: (2022)

Ghana’s herbal medicine industry: prospects, challenges and ways forward from a developing country perspective
por: Asase, Alex
Publicado: (2023)

The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light
por: Collingwood, Joanna F., et al.
Publicado: (2014)

MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders
por: Han, Dong, et al.
Publicado: (2020)

Editorial: Current Trends in Medicinal Plant Research and Neurodegenerative Disorders
por: Ayaz, Muhammad, et al.
Publicado: (2022)

Editorial: Natural products as drivers in drug development for neurodegenerative disorders
por: Silva, Joana, et al.
Publicado: (2022)

The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders
por: Wong, Bruce X., et al.
Publicado: (2014)

Role of Glia-Derived Extracellular Vesicles in Neurodegenerative Diseases
por: Li, Tianbai, et al.
Publicado: (2021)

GRK5 – A Functional Bridge Between Cardiovascular and Neurodegenerative Disorders
por: Hendrickx, Jhana O., et al.
Publicado: (2018)

The ubiquitin proteasome system in glia and its role in neurodegenerative diseases
por: Jansen, Anne H. P., et al.
Publicado: (2014)

Mesenchymal Stem Cell-Based Therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders
por: Issa, Shaza S., et al.
Publicado: (2022)

Editorial: Natural products as drivers in drug development for neurodegenerative disorders, volume II
por: Silva, Joana, et al.
Publicado: (2023)

Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting
por: Bakker, Elisabeth, et al.
Publicado: (2021)

The Treatment of Sleep Dysfunction in Neurodegenerative Disorders
por: Voysey, Zanna J., et al.
Publicado: (2020)

Current controversies in glia-to-neuron conversion therapy in neurodegenerative diseases
por: Cao, Peng, et al.
Publicado: (2023)

Impairment of Interrelated Iron- and Copper Homeostatic Mechanisms in Brain Contributes to the Pathogenesis of Neurodegenerative Disorders
por: Skjørringe, Tina, et al.
Publicado: (2012)

The Way Forward Is the Way Back
por: Potter, Polyxeni
Publicado: (2007)

The Way Forward
por: Singh, Yamuna
Publicado: (2020)

The Way Forward
Publicado: (2005)

The way forward
Publicado: (2002)

The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders
por: Urrutia, Pamela J., et al.
Publicado: (2014)

Neurodegenerative Disease and the NLRP3 Inflammasome
por: Holbrook, Jonathan A., et al.
Publicado: (2021)

A Bcr-Abl Inhibitor GNF-2 Attenuates Inflammatory Activation of Glia and Chronic Pain
por: Song, Gyun Jee, et al.
Publicado: (2019)

Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders
por: Chen, Qian, et al.
Publicado: (2021)

From tryptamine to the discovery of efficient multi-target directed ligands against cholinesterase-associated neurodegenerative disorders
por: Wu, Junbo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kg1rjn3scfrqmnhvme4v7qt9hi